This inventor holds 1 USPTO granted patent. Top assignee: St Pharm Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Hoongyu Park: Innovator in Dermatological Solutions
Introduction
Hoongyu Park is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of dermatology through his innovative research and development of new treatments.
Latest Patents
Hoongyu Park holds a patent for an ergostenol glycoside derivative. This invention provides ergostenol glycoside derivatives and a method for preventing, treating, or alleviating dermatitis. The invention also outlines a method for preparing the ergostenol and glycoside derivatives. The ergostenol and glycoside derivatives suppress the production of chemokines that increase due to skin inflammation stimulation. They also inhibit the activity of transcriptional factors that control the expression of various inflammation mediators in the prevention and treatment of dermatitis. He has 1 patent to his name.
Career Highlights
Hoongyu Park is associated with St Pharm Co., Ltd., where he continues to work on innovative solutions in dermatology. His research has the potential to significantly impact the treatment of skin conditions.
Collaborations
He collaborates with talented coworkers, including Hakwon Kim and Tae Hoon Lee, to advance his research and development efforts.
Conclusion
Hoongyu Park is a dedicated inventor whose work in dermatological innovations is paving the way for new treatments for dermatitis. His contributions are valuable to the field and hold promise for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile